Cyclopharm (CYC.AX) Earnings Analysis
Cyclopharm (CYC.AX) next reports earnings on 2026-08-17. Trailing P/E -3.61.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CYC.AX next report earnings?
| Next earnings date | 2026-08-17 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.02B |
CYC.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-27 | -0.06964 AUD | n/a | n/a | n/a |
| 2025-02-26 | -0.05173 AUD | n/a | n/a | n/a |
CYC.AX valuation and analyst view
| Trailing P/E | -3.61 |
|---|---|
| Trailing EPS | -0.15663 AUD |
| Price / book | 2.29 |
| Dividend yield | 0.00% |
| Market cap | 0.07B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Cyclopharm (CYC.AX)'s next earnings date?
Cyclopharm is next scheduled to report on 2026-08-17 and revenue estimate of 0.02B.
Did CYC.AX beat earnings last quarter?
Consensus estimate data was not available for CYC.AX's 2025-08-27 report.
What is CYC.AX's current P/E ratio and EPS?
CYC.AX trades at a trailing P/E of -3.61 on trailing EPS of -0.15662576062141292 AUD.
What do analysts rate CYC.AX?
CYC.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.